Sander Markx from Columbia University: Charting a New Future in Targeted Psychiatric Care
MAY 25, 2016
Studying the use of targeted medicines in psychiatry is still new but early studies have shown that this could be a viable treatment option in the future for some patients in need.
While most medications to treat psychiatric conditions are meant to address patient symptoms they are not all directed toward a cure for the respective conditions. Although he was not ready to say that targeted therapies could provide a cure for some of these conditions and patients Sander Markx, MD, from Columbia University said there is evidence that this field could provide a new level of treatment not seen in current traditional patient care.